{"id":"https://openalex.org/W2031834423","doi":"https://doi.org/10.1055/s-2007-1017459","title":"Hypersexuality - a Complication of Dopaminergic Therapy in Parkinson's Disease","display_name":"Hypersexuality - a Complication of Dopaminergic Therapy in Parkinson's Disease","alternate_titles":[],"publication_year":1983,"publication_date":"1983-07-01","ids":{"openalex":"https://openalex.org/W2031834423","doi":"https://doi.org/10.1055/s-2007-1017459","mag":"2031834423","pmid":"https://pubmed.ncbi.nlm.nih.gov/6685318"},"language":"en","primary_location":{"id":"doi:10.1055/s-2007-1017459","doi":"https://doi.org/10.1055/s-2007-1017459","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2007-1017459","pdf_url":null,"source":{"id":"https://openalex.org/S4122505","display_name":"Pharmacopsychiatry","issn_l":"0176-3679","issn":["0176-3679","1439-0795"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2031834423"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110472715","display_name":"H. P. Vogel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I75951250","display_name":"Freie Universit\u00e4t Berlin","ror":"https://ror.org/046ak2485","country_code":"DE","type":"education","lineage":["https://openalex.org/I75951250"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H. Vogel","raw_affiliation_strings":["Department of Neurology, Klinikum Steglitz, Free University of Berlin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Klinikum Steglitz, Free University of Berlin","institution_ids":["https://openalex.org/I75951250"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031111446","display_name":"Roland Schiffter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I75951250","display_name":"Freie Universit\u00e4t Berlin","ror":"https://ror.org/046ak2485","country_code":"DE","type":"education","lineage":["https://openalex.org/I75951250"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Schiffter","raw_affiliation_strings":["Department of Neurology, Klinikum Steglitz, Free University of Berlin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Klinikum Steglitz, Free University of Berlin","institution_ids":["https://openalex.org/I75951250"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I75951250"],"apc_list":null,"apc_paid":null,"fwci":1.3355,"has_fulltext":false,"cited_by_count":83,"citation_normalized_percentile":{"value":0.77933376,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"16","issue":"04","first_page":"107","last_page":"110"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12335","display_name":"Sexuality, Behavior, and Technology","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypersexuality","display_name":"hypersexuality","score":0.9919999837875366},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9700000286102295},{"id":"https://openalex.org/keywords/dopaminergic-therapy","display_name":"dopaminergic therapy","score":0.9020000100135803},{"id":"https://openalex.org/keywords/l-dopa","display_name":"L-DOPA","score":0.8669999837875366},{"id":"https://openalex.org/keywords/bromocriptine","display_name":"bromocriptine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6259999871253967},{"id":"https://openalex.org/keywords/hyperkinesia","display_name":"hyperkinesia","score":0.8320000171661377},{"id":"https://openalex.org/keywords/drug-abuse","display_name":"drug abuse","score":0.6620000004768372},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C2779088608","wikidata":"https://www.wikidata.org/wiki/Q267907","display_name":"Hypersexuality","level":3,"score":0.9948306083679199},{"id":"https://openalex.org/C2776856834","wikidata":"https://www.wikidata.org/wiki/Q413581","display_name":"Bromocriptine","level":4,"score":0.8749964237213135},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.752508282661438},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5879952907562256},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.5715793371200562},{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.5178087949752808},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.5040153861045837},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.46204373240470886},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.41734081506729126},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3723950982093811},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.32232868671417236},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.30456095933914185},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1428602933883667},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.09194391965866089},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D001545","descriptor_name":"Benserazide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001545","descriptor_name":"Benserazide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001971","descriptor_name":"Bromocriptine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001971","descriptor_name":"Bromocriptine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012735","descriptor_name":"Sexual Dysfunction, Physiological","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1055/s-2007-1017459","doi":"https://doi.org/10.1055/s-2007-1017459","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2007-1017459","pdf_url":null,"source":{"id":"https://openalex.org/S4122505","display_name":"Pharmacopsychiatry","issn_l":"0176-3679","issn":["0176-3679","1439-0795"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"journal-article"},{"id":"pmid:6685318","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6685318","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatria","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3215167939","https://openalex.org/W4298285663","https://openalex.org/W7125167739","https://openalex.org/W101289531","https://openalex.org/W63319997","https://openalex.org/W2424225992","https://openalex.org/W2055685887","https://openalex.org/W1978588030","https://openalex.org/W2059320340"],"abstract_inverted_index":{"Hypersexuality":[0],"induced":[1],"by":[2],"dopaminergic":[3],"drug":[4],"treatment":[5],"in":[6],"parkinsonian":[7],"patients":[8],"is":[9,17],"a":[10],"rarely":[11],"reported":[12],"side-effect.":[13],"A":[14],"case":[15],"history":[16],"presented":[18],"where":[19],"it":[20],"occurred":[21],"together":[22],"with":[23,30],"hyperkinesias":[24],"while":[25],"the":[26,41,50],"patient":[27],"was":[28],"treated":[29],"L-dopa":[31],"and":[32],"bromocriptione.":[33],"An":[34],"addictive":[35],"misuse":[36],"of":[37,43,52],"these":[38],"drugs":[39],"complicated":[40],"guidance":[42],"this":[44],"patient.":[45],"Approximately":[46],"three":[47],"years":[48],"after":[49],"beginning":[51],"hypersexuality":[53],"he":[54],"developed":[55],"several":[56],"paranoid-hallucinatory":[57],"psychoses":[58],"which":[59],"subsided":[60],"each":[61],"time":[62],"upon":[63],"dose":[64],"reduction.":[65],"Zusammenfassung":[66],"Hypersexualit\u00e4t":[67,99,116],"ist":[68],"eine":[69],"selten":[70],"berichtete":[71],"Nebenwirkung":[72],"dopaminerger":[73],"Therapie":[74],"bei":[75,85],"Patienten":[76],"mit":[77,90],"Parkinsonscher":[78],"Krankheit.":[79],"Es":[80],"wird":[81],"ein":[82],"Fall":[83],"berichtet,":[84],"dem":[86],"es":[87,118],"unter":[88],"Behandlung":[89],"L-Dopa":[91],"und":[92],"Bromocriptin":[93],"neben":[94],"Hyperkinesen":[95],"auch":[96],"zu":[97,119],"einer":[98],"kam.":[100],"Ein":[101],"s\u00fcchtiger":[102],"Mi\u00dfbrauch":[103],"dieser":[104],"Substanzen":[105],"erschwerte":[106],"die":[107,123],"Patientenf\u00fchrung":[108],"erheblich.":[109],"Etwa":[110],"drei":[111],"Jahre":[112],"nach":[113,126],"Beginn":[114],"der":[115],"kam":[117],"mehreren":[120],"paranoid-halluzinatorischen":[121],"Psychosen,":[122],"jeweils":[124],"rasch":[125],"Dosisreduktion":[127],"abklangen.":[128]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2031834423","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
